Literature DB >> 26434913

Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.

Cui-Ge Yu1, Xiang-Yang Jiang, Bin Li, Lu Gan, Jian-Feng Huang.   

Abstract

BACKGROUND: To analyze the expression of estrogen receptors (ER), progesterone receptors (PR), C-erbB-2 and Ki-67 in endometrial carcinoma (EC) and their relationships with the clinicopathological features.
MATERIALS AND METHODS: Sixty-seven EC samples, 53 normal endometrial samples and 53 atypical hyperplasia endometrial samples were all selected in Shaanxi Provincial People's Hospital from Jun., 2012 to Jun., 2014. The expression of ER, PR, C-erbB-2 and Ki-67 in EC tissue, normal endometrial tissue and atypical hyperplasia endometrial tissue was respectively detected using immunohistochemical SP method. The relationships between the expression of ER, PR, C-erbB-2 and Ki-67 and the patients' clinicopathological features as well as their correlations in EC tissue were also analyzed.
RESULTS: The positive expression rates of ER and PR in EC tissue were 44.8% and 41.8%, respectively, dramatically lower than in atypical hyperplasia endometrial tissue and normal endometrial tissue (P<0.01). The positive expression rates of C-erbB-2 and Ki-67 in EC tissue were 80.6% and 64.2%, respectively, significantly higher than in atypical hyperplasia endometrial tissue and normal endometrial tissue (P<0.01). In EC tissue, the expression of ER and PR was closely associated with the differentiated degrees and depth of myometrial invasion (P<0.05), while that of C-erbB-2 and Ki-67 with the clinical staging, differentiated degrees, depth of myometrial invasion and presence or absence of lymph node metastasis (P<0.05). Spearman correlation analysis further displayed that the expression of ER was positively correlated with PR (r=0.393, P=0.001), but negatively with C-erbB-2 and Ki-67 (r=-0.469, P=0.000; r=-0.329, P=0.007); The expression of PR was negatively correlated with C-erbB-2 and Ki-67 (r=-0.273, P=0.025; r=-0.251, P=0.041), but that of C-erbB-2 positively with Ki-67 (r=0.342, P=0.005).
CONCLUSIONS: Abnormal expression of ER, PR, C-erbB2 and Ki-67 might play an important role in endometrial malignant transformation and cell differentiation, so their joint detection is likely to be a comprehensive combination of immune factors, which is of great importance for EC prognosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26434913     DOI: 10.7314/apjcp.2015.16.15.6789

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.

Authors:  Tomasz Banas; Kazimierz Pitynski; Krzysztof Okon; Aleksandra Winiarska
Journal:  BMC Cancer       Date:  2018-04-13       Impact factor: 4.430

2.  Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.

Authors:  Wenting Li; Ying Wang; Xinzhi Fang; Mei Zhou; Yiqun Li; Ying Dong; Ruozheng Wang
Journal:  Med Sci Monit       Date:  2017-02-21

3.  Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.

Authors:  Lina Adomaitienė; Rūta Nadišauskienė; Mahshid Nickkho-Amiry; Arvydas Čižauskas; Jolita Palubinskienė; Cathrine Holland; Mourad W Seif
Journal:  Medicina (Kaunas)       Date:  2019-08-28       Impact factor: 2.430

4.  Expression of lipoma preferred partner in mammary and extramammary Paget disease.

Authors:  Ye Liu; Yangbin Wang; Ruiqun Qi; Xiaoyun Mao; Feng Jin
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

5.  Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma.

Authors:  Yu Meng; Quan Quan; Fenfen Zhang; Yao Liu; Siling Ren; Xiaoling Mu
Journal:  Front Med (Lausanne)       Date:  2022-01-25

6.  Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients.

Authors:  Junyan Zhu; Fabian Trillsch; Doris Mayr; Christina Kuhn; Martina Rahmeh; Simone Hofmann; Marianne Vogel; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Oncotarget       Date:  2017-12-09

7.  The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer.

Authors:  Birol Ocak; Fatma Öz Atalay; Ahmet Bilgehan Sahin; Mine Ozsen; Bahar Dakiki; Seray Türe; Merve Mesohorli; Hikmet Utku Odman; Özgür Tanrıverdi; Gökhan Ocakoğlu; Mehmet Bayrak; Hakan Ozan; Candan Demiröz; Seda Sali; Sibel Oyucu Orhan; Adem Deligönül; Erdem Cubukcu; Türkkan Evrensel
Journal:  Bosn J Basic Med Sci       Date:  2021-02-18       Impact factor: 3.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.